Sanofi Gains Enoxaparin Approval in Japan
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare has approved for marketing Sanofi-Aventis' low-molecular weight heparin Clexane (enoxaparin), according to Sanofi